105 related articles for article (PubMed ID: 2157555)
1. Therapy for poor-risk patients with small-cell lung cancer using bolus ifosfamide and oral etoposide.
Anderson H; Lind MJ; Thatcher N; Swindell R; Woodcock A; Carroll KB
Cancer Chemother Pharmacol; 1990; 26(1):71-4. PubMed ID: 2157555
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin, ifosfamide, and prolonged oral etoposide in the treatment of patients with extensive small cell lung carcinoma.
Glisson B; Lee JS; Palmer J; Fossella F; Shin DM; Murphy WK; Perez-Soler R; Hong WK
Cancer; 1998 Jan; 82(2):301-8. PubMed ID: 9445186
[TBL] [Abstract][Full Text] [Related]
3. A randomised study of bolus vs continuous pump infusion of ifosfamide and doxorubicin with oral etoposide for small cell lung cancer.
Anderson H; Hopwood P; Prendiville J; Radford JA; Thatcher N; Ashcroft L
Br J Cancer; 1993 Jun; 67(6):1385-90. PubMed ID: 8390287
[TBL] [Abstract][Full Text] [Related]
4. A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.
Evans WK; Stewart D; Logan D; Maroun J; Goss G; Shepherd FA; Latreille J; Warner E; Dahrouge S
Semin Oncol; 1992 Dec; 19(6 Suppl 12):51-6. PubMed ID: 1336622
[TBL] [Abstract][Full Text] [Related]
5. Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosis.
Kamthan AG; Lind MJ; Thatcher N; Steward WP; Bronchud MH; Ranson MR; Stout R
Eur J Cancer; 1990; 26(6):691-4. PubMed ID: 2168191
[TBL] [Abstract][Full Text] [Related]
6. A randomised study of intravenous bolus versus continuous infusion of ifosfamide and doxorubicin with oral etoposide for small-cell lung cancer.
Anderson H; Prendiville J; Thatcher N; Radford JA; Swindell R
J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S139-40. PubMed ID: 1665490
[TBL] [Abstract][Full Text] [Related]
7. Outpatient intensive chemotherapy for small cell lung cancer: five years experience of modified 'ICE' ifosfamide carboplatin and etoposide.
Hand S; Baker J; Smith AP; Macbeth FR
Clin Oncol (R Coll Radiol); 2002 Oct; 14(5):367-71. PubMed ID: 12555875
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small-cell lung cancer.
Chen YM; Wu MF; Perng RP; Chou CM; Yang KY; Lin WC; Tsai CM; Liu JM; Whang-Peng J
Jpn J Clin Oncol; 1997 Apr; 27(2):76-9. PubMed ID: 9152794
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
Unsal M; Erturk D
Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study.
Wolff AC; Ettinger DS; Neuberg D; Comis RL; Ruckdeschel JC; Bonomi PD; Johnson DH
J Clin Oncol; 1995 Jul; 13(7):1615-22. PubMed ID: 7602350
[TBL] [Abstract][Full Text] [Related]
11. Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small-cell lung cancer: A feasibility study by the European Group for Blood and Marrow Transplantation.
Leyvraz S; Perey L; Rosti G; Lange A; Pampallona S; Peters R; Humblet Y; Bosquée L; Pasini F; Marangolo M
J Clin Oncol; 1999 Nov; 17(11):3531-9. PubMed ID: 10550151
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
Wolf M; Havemann K; Holle R; Gropp C; Drings P; Hans K; Schroeder M; Heim M; Dommes M; Mende S
J Clin Oncol; 1987 Dec; 5(12):1880-9. PubMed ID: 2824710
[TBL] [Abstract][Full Text] [Related]
13. Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancer.
Thatcher N; Cerny T; Stout R; Anderson H; Barber PV; Wolstenholme RJ; Barnes P; Deiraniya A
Cancer; 1987 Nov; 60(10):2382-7. PubMed ID: 2822217
[TBL] [Abstract][Full Text] [Related]
14. Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer.
Smith IE; Perren TJ; Ashley SA; Woodiwiss J; Forgeson GV; Yarnold JR; Ford HT
J Clin Oncol; 1990 May; 8(5):899-905. PubMed ID: 2159056
[TBL] [Abstract][Full Text] [Related]
15. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H
Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
[TBL] [Abstract][Full Text] [Related]
16. Experience with ifosfamide and etoposide combination chemotherapy in extensive-disease small-cell lung cancer.
Wu MF; Perng RP; Chen YM; Liu JM; Yang SL; Whang-Peng J
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Aug; 60(2):67-73. PubMed ID: 9360330
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary report.
Shepherd FA; Goss PE; Latreille J; Stewart D; Logan D; Evans WK; Maroun J; Warner E
Semin Oncol; 1990 Apr; 17(2 Suppl 4):19-23. PubMed ID: 2159185
[TBL] [Abstract][Full Text] [Related]
18. A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). I: Survival and prognostic factors. Medical Research Council Lung Cancer Working Party.
Bleehen NM; Girling DJ; Machin D; Stephens RJ
Br J Cancer; 1993 Dec; 68(6):1150-6. PubMed ID: 8260367
[TBL] [Abstract][Full Text] [Related]
19. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
Strauss GM; Lynch TJ; Elias AD; Jacobs C; Herbst R; Leong T; Lynch C; Kwiatkowski DJ; Carey RW; Grossbard ML; Skarin AT
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
[TBL] [Abstract][Full Text] [Related]
20. Etoposide, ifosfamide, and cisplatin in extensive small cell lung cancer.
Loehrer PJ; Rynard S; Ansari R; Songer J; Pennington K; Einhorn L
Cancer; 1992 Feb; 69(3):669-73. PubMed ID: 1309677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
